Tricyclic AKR1C3 dependent KARS inhibitors
US11970497B2 · kind B2 · utility
0Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2020 |
| Grant date | Apr 30, 2024 |
| Priority date | — |
| Expiry date | Nov 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4747
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.